Aligos Therapeutics (ALGS) Shares Outstanding (2021 - 2025)
Historic Shares Outstanding for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $6.2 million.
- Aligos Therapeutics' Shares Outstanding rose 8508.01% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 8508.01%. This contributed to the annual value of $3.9 million for FY2024, which is 2864.92% up from last year.
- As of Q3 2025, Aligos Therapeutics' Shares Outstanding stood at $6.2 million, which was up 8508.01% from $6.2 million recorded in Q2 2025.
- Aligos Therapeutics' 5-year Shares Outstanding high stood at $42.9 million for Q1 2023, and its period low was $1.7 million during Q4 2022.
- Its 5-year average for Shares Outstanding is $19.6 million, with a median of $6.2 million in 2025.
- Per our database at Business Quant, Aligos Therapeutics' Shares Outstanding tumbled by 9597.82% in 2022 and then soared by 10202.71% in 2025.
- Over the past 5 years, Aligos Therapeutics' Shares Outstanding (Quarter) stood at $42.7 million in 2021, then plummeted by 95.98% to $1.7 million in 2022, then skyrocketed by 74.96% to $3.0 million in 2023, then rose by 28.65% to $3.9 million in 2024, then skyrocketed by 59.23% to $6.2 million in 2025.
- Its Shares Outstanding was $6.2 million in Q3 2025, compared to $6.2 million in Q2 2025 and $6.1 million in Q1 2025.